PATENT CLAIM ANALYSIS

Application Number: 16152735
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-01
Patent Classification: ["544", "331000"]

Abstract:
Disclosed are inhibitors of human galactokinase of formula (I) that are useful in treating or preventing a galactokinase mediated disease or disorder, e.g., galactosemia. Also disclosed are a composition comprising a pharmaceutically acceptable carrier and at least one inhibitor of the invention, and a method of treating or preventing such disease or disorder in a mammal. Formula (I).

Claim (Index 19):
The method of claim  37 , wherein the compound is delivered with a pharmaceutical carrier.

Metadata:
- Claim Count in Document: 48.0
- Percentile: 97.0
- Lexical Diversity: 1.61905
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14346400', '14409374', '10715662', '10559405', '16119962']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7987893005016792
- 35 USC 102 Novelty (BERT): 0.5199798413688519
- Combined Prediction Score: 0.7709083545883965
- Mean Citation Score: 260.10813
- Max Citation Score: 287.9479
- Similarity Product: 154.25759271131753

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test